Re - Heartbreaking Results

When Pfizer, a giant drug manufacturer decided to abandon torcetrapib a blockbuster drug, intended to treat heart disease and a project that had gulped millions of Dollars. Simply because 82 people had died died during the trial.

But why is a there a major variance between patient safety and quality ? , or the popularity of the yet to be certified drug had overwhelmed the quality and precisions in which Pfizer is known for ? and all these had gradually metamorphosised to profit motives instead of patient safety and security.

Halting the development of these drug should not be the solution, but making sure that the drug does not get beyond the confine of the manufacturers premises, so that it will not find its way to the wrong channel where dubious and desperate business men are reigning supreme.